Wedbush Expects Positive Results from Insmed (INSM) ARIKAC Trial

Go back to Wedbush Expects Positive Results from Insmed (INSM) ARIKAC Trial
INSMED (NASDAQ: INSM) Delayed: 123.74 --0 (-0%)
Previous Close $123.74    52 Week High $19.30 
Open $123.74    52 Week Low $9.02 
Day High $123.74    P/E N/A 
Day Low $123.74    EPS $-1.69 
Volume 1,224